Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $30.1 million.

  • Profound Medical's Shares Outstanding (Diluted Average) changed N/A to $30.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.1 million, marking a year-over-year change of. This contributed to the annual value of $24.8 million for FY2024, which is 1691.46% up from last year.
  • Profound Medical's Shares Outstanding (Diluted Average) amounted to $30.1 million in Q3 2025.
  • Over the past 5 years, Profound Medical's Shares Outstanding (Diluted Average) peaked at $30.1 million during Q3 2025, and registered a low of $21.2 million during Q4 2023.
  • Over the past 3 years, Profound Medical's median Shares Outstanding (Diluted Average) value was $30.0 million (recorded in 2025), while the average stood at $27.2 million.
  • Data for Profound Medical's Shares Outstanding (Diluted Average) shows a peak YoY increase of 1691.46% (in 2024) and a maximum YoY decrease of 1691.46% (in 2024) over the last 5 years.
  • Over the past 3 years, Profound Medical's Shares Outstanding (Diluted Average) (Quarter) stood at $21.2 million in 2023, then increased by 16.91% to $24.8 million in 2024, then rose by 21.62% to $30.1 million in 2025.
  • Its last three reported values are $30.1 million in Q3 2025, $30.1 million for Q2 2025, and $30.0 million during Q1 2025.